Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
06 07 2023
Historique:
received: 26 03 2023
revised: 18 05 2023
accepted: 19 05 2023
medline: 10 7 2023
pubmed: 11 6 2023
entrez: 10 6 2023
Statut: ppublish

Résumé

Although the best-known spinocerebellar ataxias (SCAs) are triplet repeat diseases, many SCAs are not caused by repeat expansions. The rarity of individual non-expansion SCAs, however, has made it difficult to discern genotype-phenotype correlations. We therefore screened individuals who had been found to bear variants in a non-expansion SCA-associated gene through genetic testing, and after we eliminated genetic groups that had fewer than 30 subjects, there were 756 subjects bearing single-nucleotide variants or deletions in one of seven genes: CACNA1A (239 subjects), PRKCG (175), AFG3L2 (101), ITPR1 (91), STUB1 (77), SPTBN2 (39), or KCNC3 (34). We compared age at onset, disease features, and progression by gene and variant. There were no features that reliably distinguished one of these SCAs from another, and several genes-CACNA1A, ITPR1, SPTBN2, and KCNC3-were associated with both adult-onset and infantile-onset forms of disease, which also differed in presentation. Nevertheless, progression was overall very slow, and STUB1-associated disease was the fastest. Several variants in CACNA1A showed particularly wide ranges in age at onset: one variant produced anything from infantile developmental delay to ataxia onset at 64 years of age within the same family. For CACNA1A, ITPR1, and SPTBN2, the type of variant and charge change on the protein greatly affected the phenotype, defying pathogenicity prediction algorithms. Even with next-generation sequencing, accurate diagnosis requires dialogue between the clinician and the geneticist.

Identifiants

pubmed: 37301203
pii: S0002-9297(23)00166-0
doi: 10.1016/j.ajhg.2023.05.009
pmc: PMC10357418
pii:
doi:

Substances chimiques

AFG3L2 protein, human EC 3.4.24.-
ATPases Associated with Diverse Cellular Activities EC 3.6.4.-
ATP-Dependent Proteases EC 3.4.21.-
STUB1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1098-1109

Subventions

Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom

Informations de copyright

Copyright © 2023 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interest.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Brain. 2017 Jun 1;140(6):1579-1594
pubmed: 28444220
Neuropharmacology. 1997 Mar;36(3):405-9
pubmed: 9175621
Brain. 2009 Oct;132(Pt 10):2688-98
pubmed: 19696032
Nat Rev Dis Primers. 2019 Apr 11;5(1):24
pubmed: 30975995
Clin Genet. 2022 Oct;102(4):288-295
pubmed: 35722745
Cell Rep. 2019 Jan 29;26(5):1189-1202.e6
pubmed: 30699348
Cerebellum. 2013 Jun;12(3):418-28
pubmed: 23090211
Ann Neurol. 2022 Jul;92(1):122-137
pubmed: 35411967
Hum Mutat. 2010 Feb;31(2):191-6
pubmed: 19953606
Genet Med. 2022 Jan;24(1):29-40
pubmed: 34906452
Lancet Neurol. 2010 Sep;9(9):885-94
pubmed: 20723845
Neuroepidemiology. 2014;42(3):174-83
pubmed: 24603320
Eur J Neurol. 2020 Nov;27(11):2267-2276
pubmed: 32558018
Neurology. 2006 Jun 13;66(11):1717-20
pubmed: 16769946
Trends Neurosci. 1998 Apr;21(4):148-54
pubmed: 9554724
Cerebellum. 2019 Aug;18(4):817-822
pubmed: 31111429
Eur J Hum Genet. 2018 Nov;26(11):1623-1634
pubmed: 29925855
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Lancet Neurol. 2004 May;3(5):291-304
pubmed: 15099544
Hum Mol Genet. 1997 Oct;6(11):1973-8
pubmed: 9302278
Genet Med. 2023 Feb;25(2):100327
pubmed: 36422518
Brain. 2017 Nov 1;140(11):2860-2878
pubmed: 29053796
Hum Genet. 2019 Sep;138(8-9):881-898
pubmed: 30242502
Ann Clin Transl Neurol. 2021 Apr;8(4):956-963
pubmed: 33756041
Eur J Neurosci. 2007 Nov;26(10):2950-61
pubmed: 18001290
Proc Natl Acad Sci U S A. 2021 Oct 5;118(40):
pubmed: 34580197
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W252-8
pubmed: 24782522
PLoS Genet. 2020 Oct 19;16(10):e1009118
pubmed: 33075064
FASEB J. 2019 Dec;33(12):13852-13865
pubmed: 31648575
Genet Med. 2020 Nov;22(11):1851-1862
pubmed: 32713943
Neurodegener Dis. 2009;6(1-2):16-22
pubmed: 19066432
J Child Neurol. 2020 Feb;35(2):106-110
pubmed: 31617442
Mol Cell Oncol. 2017 Sep 28;4(6):e1372867
pubmed: 29209655

Auteurs

Paulina Cunha (P)

Sorbonne Université, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, CS21414, 75646 PARIS Cedex 13, France.

Emilien Petit (E)

Sorbonne Université, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, CS21414, 75646 PARIS Cedex 13, France.

Marie Coutelier (M)

Sorbonne Université, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, CS21414, 75646 PARIS Cedex 13, France.

Giulia Coarelli (G)

Sorbonne Université, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, CS21414, 75646 PARIS Cedex 13, France.

Caterina Mariotti (C)

Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Jennifer Faber (J)

German Center for Neurodegenerative Disease (DZNE), 53127 Bonn, Germany; Department of Neurology, University Hospital of Bonn, 53111 Bonn, Germany.

Judith Van Gaalen (J)

Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, 6525 Nijmegen, the Netherlands.

Joana Damasio (J)

Neurology Department, Hospital de Santo António, Centro Hospitalar Universitário de Santo António, 4099-001 Porto, Portugal; CGPP, IBMC-Institute for Molecular and Cell Biology & UnIGENe, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.

Zofia Fleszar (Z)

German Center for Neurodegenerative Disease (DZNE), 72076 Tübingen, Germany; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, 72076 Tübingen, Germany.

Michele Tosi (M)

Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesu' Children's Research Hospital, IRCCS, 00165 Rome, Italy.

Clarissa Rocca (C)

Department of Neuromuscular Diseases, UCL Queen's Square Institute of Neurology, Queen's Square House, Queen's Square, WC1N 3BG London, UK.

Giovanna De Michele (G)

Department of Neuroscience and Reproductive and Odontostomatological Sciences, University of Naples Federico II, 80131 Naples, Italy.

Martina Minnerop (M)

Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, 52428 Jülich, Germany; Institute of Clinical Neuroscience and Medical Psychology and Department of Neurology, Center for Movement Disorders and Neuromodulation, Medical Faculty & University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.

Claire Ewenczyk (C)

Sorbonne Université, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, CS21414, 75646 PARIS Cedex 13, France.

Filippo M Santorelli (FM)

Molecular Medicine & Neurogenetics, IRCCS Fondazione Stella Maris, 56128 Calambrone, Italy.

Anna Heinzmann (A)

Sorbonne Université, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, CS21414, 75646 PARIS Cedex 13, France.

Thomas Bird (T)

University of Washington, Seattle, WA 98195, USA.

Matthias Amprosi (M)

Center for Rare Movement Disorders, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Elisabetta Indelicato (E)

Center for Rare Movement Disorders, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Alberto Benussi (A)

Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, 25121 Brescia, Italy.

Perrine Charles (P)

Sorbonne Université, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, CS21414, 75646 PARIS Cedex 13, France.

Claudia Stendel (C)

German Center for Neurodegenerative Disease (DZNE), München, Germany; Department of Neurology, Friedrich-Baur Institute, University Hospital of Ludwig-Maximilians-University, Munich Cluster for Systems Neurology (SyNergy), 80336 Munich, Germany.

Silvia Romano (S)

Neurosciences, Mental Health, and Sensory Organs (NESMOS) Department, S. Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.

Marina Scarlato (M)

San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy.

Isabelle Le Ber (I)

Sorbonne Université, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, CS21414, 75646 PARIS Cedex 13, France.

Maria Teresa Bassi (MT)

Scientific Institute I.R.C.C.S. Eugenio Medea, 23842 Bosisio Parini, Italy.

Mercedes Serrano (M)

Pediatric Neurology Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain.

Tanja Schmitz-Hübsch (T)

Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.

Sarah Doss (S)

Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.

Gijs A J Van Velzen (GAJ)

Department of Neurology, Leiden University Medical Center, 2333 Leiden, the Netherlands.

Quentin Thomas (Q)

Department of Clinical Genetics, Dijon University Hospital, 21000 Dijon, France.

Antonio Trabacca (A)

Scientific Institute I.R.C.C.S. Eugenio Medea, 23842 Bosisio Parini, Italy.

Juan Dario Ortigoza-Escobar (JD)

Pediatric Neurology Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain.

Stefano D'Arrigo (S)

Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Dagmar Timmann (D)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.

Chiara Pantaleoni (C)

Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Andrea Martinuzzi (A)

Scientific Institute I.R.C.C.S. Eugenio Medea, 23842 Bosisio Parini, Italy.

Elsa Besse-Pinot (E)

Department of Neurology, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France.

Luca Marsili (L)

Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH 45219, USA.

Ettore Cioffi (E)

Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino, 04100 Latina, Italy.

Francesco Nicita (F)

Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesu' Children's Research Hospital, IRCCS, 00165 Rome, Italy.

Alejandro Giorgetti (A)

Computational Biomedicine, Institute for Advanced Simulations IAS-5 and Institute of Neuroscience and Medicine INM-9, Forschungszentrum Jülich GmbH, 52428 Jülich, Germany; Department of Biotechnology, Università degli Studi di Verona, 37134 Verona, Italy.

Isabella Moroni (I)

Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Romina Romaniello (R)

Scientific Institute I.R.C.C.S. Eugenio Medea, 23842 Bosisio Parini, Italy.

Carlo Casali (C)

Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino, 04100 Latina, Italy.

Penina Ponger (P)

Neurology Department, Tel-Aviv Sourasky Medical Center, 6329302 Tel-Aviv, Israel; Sackler School of Medicine, Tel-Aviv University, 6997801 Tel-Aviv, Israel.

Giorgio Casari (G)

San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy.

Susanne T De Bot (ST)

Department of Neurology, Leiden University Medical Center, 2333 Leiden, the Netherlands.

Giovanni Ristori (G)

Neurosciences, Mental Health, and Sensory Organs (NESMOS) Department, S. Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.

Lubov Blumkin (L)

Sackler School of Medicine, Tel-Aviv University, 6997801 Tel-Aviv, Israel; Pediatric Movement Disorders Clinic, Pediatric Neurology Unit, Wolfson Medical Center, 5822012 Holon, Israel.

Barbara Borroni (B)

Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, 25121 Brescia, Italy.

Cyril Goizet (C)

University Bordeaux, Equipe « Neurogénétique Translationnelle - NRGEN », INCIA CNRS UMR5287 Université Bordeaux and Centre de Reference Maladies Rares « Neurogénétique », Service de Génétique Médicale, Bordeaux University Hospital (CHU Bordeaux), 33000 Bordeaux, France.

Cecilia Marelli (C)

MMDN, University Montpellier, EPHE, INSERM and Expert Center for Neurogenetic Diseases, CHU, 34095 Montpellier, France.

Sylvia Boesch (S)

Center for Rare Movement Disorders, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Mathieu Anheim (M)

Department of Neurology, Strasbourg University Hospital, 67098 Strasbourg, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964; CNRS-UMR7104; University of Strasbourg, 67400 Illkirch-Graffenstaden, France.

Alessandro Filla (A)

Department of Neuroscience and Reproductive and Odontostomatological Sciences, University of Naples Federico II, 80131 Naples, Italy.

Henry Houlden (H)

Department of Neuromuscular Diseases, UCL Queen's Square Institute of Neurology, Queen's Square House, Queen's Square, WC1N 3BG London, UK.

Enrico Bertini (E)

Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesu' Children's Research Hospital, IRCCS, 00165 Rome, Italy.

Thomas Klopstock (T)

German Center for Neurodegenerative Disease (DZNE), München, Germany; Department of Neurology, Friedrich-Baur Institute, University Hospital of Ludwig-Maximilians-University, Munich Cluster for Systems Neurology (SyNergy), 80336 Munich, Germany.

Matthis Synofzik (M)

German Center for Neurodegenerative Disease (DZNE), 72076 Tübingen, Germany; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, 72076 Tübingen, Germany.

Florence Riant (F)

Department of Neurovascular Molecular Genetics, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, 75010 Paris, France.

Ginevra Zanni (G)

Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesu' Children's Research Hospital, IRCCS, 00165 Rome, Italy.

Stefania Magri (S)

Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Daniela Di Bella (D)

Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Lorenzo Nanetti (L)

Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Jorge Sequeiros (J)

CGPP, IBMC-Institute for Molecular and Cell Biology & UnIGENe, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.

Jorge Oliveira (J)

CGPP, IBMC-Institute for Molecular and Cell Biology & UnIGENe, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.

Bart Van de Warrenburg (B)

Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, 6525 Nijmegen, the Netherlands.

Ludger Schöls (L)

German Center for Neurodegenerative Disease (DZNE), 72076 Tübingen, Germany; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, 72076 Tübingen, Germany.

Franco Taroni (F)

Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Alexis Brice (A)

Sorbonne Université, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, CS21414, 75646 PARIS Cedex 13, France.

Alexandra Durr (A)

Sorbonne Université, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, CS21414, 75646 PARIS Cedex 13, France. Electronic address: alexandra.durr@icm-institute.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH